| Date Filed | Type | Description |
| 08/23/2023 |
SC 13G
| Altium Capital Management LP reports a 5.7% stake in Alimera Sciences, Inc |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/26/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2023 |
SC 13G/A
| Altium Capital Management LP reports a 5.7% stake in Xtant Medical Holdings, Inc. |
| 02/14/2023 |
SC 13G/A
| Altium Capital Management LP reports a 5.6% stake in HyreCar Inc. |
| 02/14/2023 |
SC 13G/A
| Altium Capital Management LP reports a 5% stake in Muscle Maker, Inc. |
| 02/14/2023 |
SC 13G/A
| Altium Capital Management LP reports a 0% stake in NeuroBo Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Altium Capital Management LP reports a 0% stake in Palisade Bio, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/21/2022 |
SC 13G
| Altium Capital Management LP reports a 5.2% stake in Astria Therapeutics, Inc. |
| 11/17/2022 |
SC 13G
| Altium Capital Management LP reports a 7.7% stake in NeuroBo Pharmaceuticals, Inc. |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G
| Altium Capital Management LP reports a 10% stake in Palisade Bio, Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 5% stake in Quoin Pharmaceuticals Ltd. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 5% stake in Palisade Bio, Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 2.1% stake in Regulus Therapeutics Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 0% stake in Urban-Gro, Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 5% stake in Ocuphire Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 5% stake in Timber Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 0% stake in electroCore, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 0% stake in INmune Bio, Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 5% stake in BioRestorative Therapies, Inc. |
| 02/14/2022 |
SC 13G/A
| Altium Capital Management LP reports a 0% stake in Hepion Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G
| Altium Capital Management LP reports a 5% stake in Renovacor, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Altium Capital Management LP reports a 5% stake in 1847 Goedeker Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|